Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial. Miller DH, Weber T, Grove R, Wardell C, Horrigan J, Graff O, Atkinson G, Dua P, Yousry T, Macmanus D, et al. Lancet Neurol. 2012 Feb; 11(2):131-9. Epub 2012 Jan 05. PMID: 22226929. Abstract CommentRecommendBookmarkWatch